• Journals Master List
  • DOAJ
  • 数据库logo
  • EuroPub
Zhu Xiao-rui, Lu Ming, Guo Quan-quan. Correlation of monocyte/high density lipoprotein and urinary albumin/creatinine ratio with the severity and prognosis of diabetic nephropathy[J]. Journal of Clinical Nephrology, 2025, 25(3): 194-200. DOI: 10.3969/j.issn.1671-2390.2025.03.003
Citation: Zhu Xiao-rui, Lu Ming, Guo Quan-quan. Correlation of monocyte/high density lipoprotein and urinary albumin/creatinine ratio with the severity and prognosis of diabetic nephropathy[J]. Journal of Clinical Nephrology, 2025, 25(3): 194-200. DOI: 10.3969/j.issn.1671-2390.2025.03.003

Correlation of monocyte/high density lipoprotein and urinary albumin/creatinine ratio with the severity and prognosis of diabetic nephropathy

More Information
  • Received Date: March 13, 2024
  • Objective To investigate the correlation of monocyte/high-density lipoprotein ratio (MHR) and urinary albumin/creatinine ratio (UACR) with the severity and prognosis of diabetic kidney disease (DKD). Methods A total of 115 DKD patients treated in Bengbu Second People's Hospital from May 1, 2021 to May 1, 2022 were prospectively enrolled. They were divided into stage 1 group, stage 2 group, stage 3 group and stage 4 group according to the degree of renal pathological injury. MHR and UACR of each group were compared, and Spearman correlation analysis was used to evaluate the correlation of MHR and UACR with DKD severity. After discharge, patients were followed up by outpatient visit or telephone contact for 1 year. According to whether they developed end-stage renal disease (ESRD), the patients were divided into good prognosis group and poor prognosis group. Logistic multivariate regression analysis was used to identify the risk factors for the prognosis of DKD patients. The receiver operating characteristic curve (ROC) was plotted to evaluate the efficacy of MHR and UACR in predicting the poor prognosis of DKD. Results There were significant differences in MHR and UACR among DKD patients with different stages (P<0.05). The lowest MHR and UACR were detected in stage 1 group [(5.35 ± 0.45) and (10.62 ± 2.15), respectively], and the highest values were found in stage 4 group [(9.35 ± 1.02) and (200.50 ± 40.58), respectively]. Spearman correlation analysis showed that MHR and UACR were positively correlated with the severity of DKD (r=0.867, 0.905, P<0.05). There were significant differences in HBA1c [(9.71 ± 1.08)% vs(12.95 ± 1.17)%], total cholesterol [(4.80 ± 0.85) mmol/L vs(8.56 ± 1.75) mmol/L], triglyceride [(1.46 ± 0.22) mmol/L vs(3.46 ± 0.52) mmol/L], serum creatinine [(89.12 ± 10.30) μmol/L vs(170.44 ± 22.85) μmol/L], serum uric acid [(5.18 ± 0.75) μmol/L vs(7.96 ± 1.16) μmol/L], cystatin C [(0.90 ± 0.15) mg/L vs(1.88 ± 0.42) mg/L], low density lipoprotein [(1.89 ± 0.46) mmol/L vs [(3.85 ± 0.69) mmol/L], MHR [(4.38 ± 0.29) vs(11.05 ± 0.85)] and UACR [(21.69 ± 4.10) vs (170.16 ± 26.50)] between good and bad prognosis groups (P<0.05). Logistic multivariate regression analysis showed that hemoglobin A1c (OR=2.344, 95% CI: 1.925-2.764), total cholesterol (OR=2.208, 95% CI: 1.940-2.476), triglyceride (OR=2.234, 95% CI: 1.986-2.363), serum creatinine (OR=2.328, 95% CI: 2.025-2.631), serum uric acid (OR=2.351, 95% CI: 2.082-2.621), cystatin C (OR=2.363, 95% CI: 2.071-2.655), low density lipoprotein (OR=2.421, 95% CI: 2.165-2.676), MHR (OR=2.489, 95% CI: 2.109-2.870), UACR (OR=2.537, 95% CI: 2.106-2.968) were independent risk factors for poor prognosis of DKD. The above indicators were all correlated with the prognosis of DKD. ROC curve showed that the sensitivity and AUC of MHR combined with UACR in predicting the poor prognosis of DKD were 90.50% and 0.896, respectively, which were significantly higher than those of MHR (84.50%, 0.871) and UACR (82.50%, 0.853) alone. Conclusion MHR and UACR are correlated with DKD severity and patient prognosis, and the combination of MHR and UACR is more effective in predicting poor prognosis of DKD.
  • [1]
    Yasuda I, Hasegawa K, Sakamaki Y, et al. Pre-emptive short-term nicotinamide mononucleotide treatment in a mouse model of diabetic nephropathy[J].J Am Soc Nephrol, 2021, 32(6): 1355-1370. DOI: 10.1681/ASN.2020081188.
    [2]
    赵娟, 彭海林, 韩俊岭, 等. 糖尿病肾脏疾病患者血清β-羟基丁酸浓度与左心室肥厚的关系[J]. 临床肾脏病杂志, 2023, 23(1): 24-30. DOI: 10.3969/j.issn.1671-2390.2023.01.005.

    Zhao J, Peng HL, Han JL, et al. Relationship betweenβ-hydroxybutyrate concentration and left ventricular hypertrophy in patients with diabetic kidney disease[J]. J Clin Nephrol , 2023, 23(1): 24-30. DOI: 10.3969/j.issn.1671-2390.2023.01.005.
    [3]
    Liakopoulos V, Georgianos PI. Exploring the high burden of cardiovascular disease among patients with end-stage renal disease[J]. Curr Vasc Pharmacol, 2021, 19(1): 1-3. DOI: 10.2174/157016111901201028093749.
    [4]
    吴美豪, 曹慧霞, 王丽姣, 等. 单核细胞/高密度脂蛋白比值与慢性肾脏病疾病严重程度及预后的关系[J]. 中华肾脏病杂志, 2021, 37(7): 567-575. DOI: 10.3760/cma.j.cn441217-20210202-00086.

    Wu MH, Cao HX, Wang LJ, et al. Relationship between monocyte/high-density lipoprotein ratio and severity and prognosis of chronic kidney disease[J]. Chin J Nephrol, 2021, 37(7): 567-575. DOI: 10.3760/cma.j.cn441217-20210202-00086.
    [5]
    Eyyupkoca F, Yildirim O, Sivri S, et al. Admission monocyte/HDL ratio predicts adverse cardiac remodeling after st-elevation myocardial infarction[J]. Rev Invest Clin, 2022, 74(2): 104-112. DOI: 10.24875/RIC.21000599.
    [6]
    Guan HL, Liu H, Hu XY, et al. Urinary albumin creatinine ratio associated with postoperative delirium in elderly patients undergoing elective non-cardiac surgery: a prospective observational study[J]. CNS Neurosci Ther, 2022, 28(4): 521-530. DOI: 10.1111/cns.13717.
    [7]
    中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志, 2018, 10(1): 4-67. DOI: 10.3760/cma.j.issn.1674-5809.2018.01.003.

    Diabetes Society of Chinese Medical Association. Chinese Guidelines for prevention and treatment of type 2 diabetes in China (2017 edition)[J]. Chin J Pract Intern Med, 2018, 10(1): 4-67. DOI: 10.3760/cma.j.issn.1674-5809.2018.01.003.
    [8]
    中华医学会糖尿病学分会微血管并发症学组.中国糖尿病肾脏疾病防治临床指南[J].中华糖尿病杂志, 2019, 11(1): 15-28. DOI: 10.3760/cma.j.issn.1674-5809.2019.01.004.

    Microvascular Complications Group, Diabetes Society, Chinese Medical Association. Chinese clinical guidelines for prevention and treatment of diabetic kidney disease[J]. Chin J Diabetes Mellit, 2019, 11(1): 15-28. DOI: 10.3760/cma.j.issn.1674-5809.2019.01.004.
    [9]
    Anderson CAM, Nguyen HA. Nutrition education in the care of patients with chronic kidney disease and end-stage renal disease[J]. Semin Dial, 2018, 31(2): 115-121. DOI: 10.1111/sdi.12681.
    [10]
    耿金平, 邱攀博, 吕莎莎. 活血益肾方联合钠-葡萄糖协同转运蛋白2抑制剂治疗糖尿病肾脏疾病的临床研究[J]. 临床肾脏病杂志, 2022,22(6): 471-477. DOI: 10.3969/j.issn.1671-2390.2022.06.005.

    Geng JP, Qiu PB, Lyu SS. Clinical study of Huoxue Yishen recipe combined with sodium-glucose co-transporter 2 inhibitor in the treatment of diabetic kidney disease[J]. J Clin Nephrol, 2022, 22(6): 471-477. DOI: 10.3969/j.issn.1671-2390.2022.06.005.
    [11]
    Acar B, Yayla C, Gul M, et al. Monocyte-to-HDL-cholesterol ratio is associated with ascending aorta dilatation in patients with bicuspid aortic valve[J]. Afr Health Sci, 2021, 21(1): 96-104. DOI: 10.4314/ahs.v21i1.14.
    [12]
    陈月梅, 张春莹, 龙婷婷, 等. 随机尿蛋白、尿蛋白/肌酐比值及尿微量白蛋白/肌酐比值在早期糖尿病肾病中应用价值[J]. 临床军医杂志, 2023, 51(4): 362-365, 369. DOI: 10.16680/j.1671-3826.2023.04.07.

    Chen YM, Zhang CY, Long TT, et al. Application value of random urine protein, urinary albumin/urinary creatinine ratio and urine microalbumine creatinine ratio in early diabetic nephropathy[J]. Clin J Med Offic, 2023, 51(4): 362-365, 369. DOI: 10.16680/j.1671-3826.2023.04.07.
    [13]
    Wang YJ, Yue SL, Cai F, et al. Treatment of berberine alleviates diabetic nephropathy by reducing iron overload and inhibiting oxidative stress[J]. Histol Histopathol, 2023, 38(9): 1009-1016. DOI: 10.14670/HH-18-599.
    [14]
    Herkiloglu D, Gokce S. Correlation of monocyte/HDL ratio (MHR) with inflammatory parameters in obese patients diagnosed with polycystic ovary syndrome[J]. Ginekol Pol,2021, 92(8): 537-543. DOI: 10.5603/GP.a2020.0191.
    [15]
    Tani S, Atsumi W, Imatake K, et al. Associations of higher fish consumption and lifestyle with lower monocyte/HDL-C ratio in a Japanese population: Implication for the anti-atherosclerotic effect of fish consumption[J]. J Cardiol, 2022, 80(5): 402-409. DOI: 10.1016/j.jjcc.2022.06.010.
    [16]
    王丽之, 黄若妃, 吕美艳, 等. 老年糖尿病肾病患者血清糖化血红蛋白、IL-6、胱抑素C与肾小球滤过率的相关性分析[J]. 中华全科医学, 2022, 20(6): 1019-1021, 1055. DOI: 10.16766/j.cnki.issn.1674-4152.002514.

    Wang LZ, Huang RF, Lyu MY, et al. Correlation analysis of serum glycosylated haemoglobin, interleukin-6 and cystatin C with GFR in elderly patients with diabetic nephropathy[J]. Chin J Gen Pract, 2022, 20(6): 1019-1021, 1055. DOI: 10.16766/j.cnki.issn.1674-4152.002514.
    [17]
    Tang GY, Li S, Zhang C, et al. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management[J]. Acta Pharm Sin B,2021,11(9):2749-2767.DOI:10.1016/j.apsb. 2020. 12.020.
    [18]
    Balu D, Krishnan V, Krishnamoorthy V, et al. Does serum kidney injury molecule-1 predict early diabetic nephropathy: a comparative study with microalbuminuria[J]. Ann Afr Med, 2022, 21(2): 136-139. DOI: 10.4103/aam.aam_92_20.
    [19]
    Akpınar K, Aslan D, Fenkçi SM. Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy[J]. J Bras Nefrol, 2021, 43(3): 340-348. DOI: 10.1590/2175-8239-JBN-2020-0145.

Catalog

    Article views (10) PDF downloads (2) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return